Mark Cuban's Cost Plus Drugs and Humana are exploring a potential partnership to help lower the cost of prescription drugs ...
The insurer continues to try to prove that regulators acted arbitrarily in downgrading its quality scores for 2025, despite ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback